|The INFLUENZA A H3N2 n/a (Catalog #MBS220956) is an Antibody produced from Goat and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s INFLUENZA A H3N2 can be used in a range of immunoassay formats including, but not limited to, Haemagglutination (H), Immunofluorescence (IF). Researchers should empirically determine the suitability of the INFLUENZA A H3N2 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
MBS220956 is specific for H3N2 by Haemagglutination inhibition. MBS220956 does not react with influenza B, RSV, Para 1-3 or Adenovirus, but may react with proteins present on uninfected chicken cells. Influenza type A viruses are divided into subtypes based on the antigenic differences of two viral surface proteins, hemagglutinin (H) and neuraminidase (N). On infection of the respiratory tract, the hemagglutinin molecule binds to sialic acid-containing receptors on the epithelial cells resulting in endocytosis. Once the virus has been engulfed, the hemagglutinin allows the viral membrane to fuse with the endosomal membrane. Neuraminidase functions to aid viral release from host cells by cleaving terminal sialic acid residues from carbohydrate moieties on the cell surface.Subtype antigenic variations result from a process known as antigenic drift whereby these surface proteins constantly mutate in order to evade the host immune response.
Perservative Stabilisers: 0.09% Sodium Azide (NaN3). Immunogen: Influenza A, Texas 1/77 strain (H3N2).
Buffer Solution: Phosphate buffered saline
Target Species: Viral. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing INFLUENZA A H3N2 are readily searchable from our website. Different antibodies against the same target such as INFLUENZA A H3N2 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.